Evaluation of the effect of curcumin in improving patients with covid -19

Phase 3

• Conditions: covid-19.; virus not identified; U07.2

• Registration Number: IRCT20200514047445N1
• Lead Sponsor: Bandare-abbas University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Satisfaction to participate in the study
Aged 18-70 years
Real Time PCR or CT-SCAN positive test

Exclusion Criteria

Bile problem
Curcumin allergy problems
Cardiovascular diseases
Use of anticoagulants

Study & Design

• Study Type: interventional
• Study Design: Not specified